Last updated at 07 Jul 2024 10:18 PM
Director
DIN: 07902887
Jophy Jose is currently associated with 3 companies in various capacities such as Director and Partner. They serve as a Director at NUCLEIC HEALTH INNOVATIONS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07902887.Jophy Jose has previously been associated with 1 company in roles such as Additional Director.Jophy Jose is currently involved in 2 different roles. Their most recent position is with TECFORZ INNOVATIONS PRIVATE LIMITED as a Director. The first company Jophy Jose was appointed to as a director was NUCLEIC HEALTH INNOVATIONS PRIVATE LIMITED. Jophy Jose is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Jophy Jose is currently associated with 3 companies in various capacities such as Director and Partner. They serve as a Director at NUCLEIC HEALTH INNOVATIONS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07902887.Jophy Jose has previously been associated with 1 company in roles such as Additional Director.Jophy Jose is currently involved in 2 different roles. Their most recent position is with TECFORZ INNOVATIONS PRIVATE LIMITED as a Director. The first company Jophy Jose was appointed to as a director was NUCLEIC HEALTH INNOVATIONS PRIVATE LIMITED. Jophy Jose is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (1)
Past Companies (1)
1y 8m 10 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| NUCLEIC HEALTH INNOVATIONS PRIVATE LIMITED | Director | 29-Dec-2018 |
| TECFORZ INNOVATIONS PRIVATE LIMITED | Director | 03-Nov-2023 |